AlphaYou
Overview
Smart money at a glance
Filings to Oct 6, 2026Net selling: insiders sold $4.2M and bought $613K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$3.5M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 6- Open
- $120.33
- 52-wk high
- $141.28
- High
- $120.33
- 52-wk low
- $73.20
- Low
- $117.67
- Prev close
- $119.24
- Mkt cap
- $5.66B
- P/E
- 10.5x
- Volume
- 1.01M
- Fwd P/E
- 8.2x
- Beta
- 1.51
- P/S
- 1.4x
- P/B
- 4.3x
- Profit margin
- +14.6%
- Op margin
- +24.2%
- ROE
- +42.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CROX filings
Are insiders buying or selling Crocs Inc (CROX) stock?
Net selling: insiders sold $4.2M and bought $613K of CROX stock on the open market in the 90 days to Oct 6, 2026, according to SEC Form 4 filings. The largest was Rees, Andrew (Chief Executive Officer), who sold $4.2M. The latest filing was on Sep 16, 2026.
Which members of Congress have traded CROX recently?
None. No member of Congress disclosed a CROX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CROX smart-money data?
This summary uses filings available on Oct 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
What insiders are doing
Buys (3)
- KB
Kaplan Beth J
$99K
bought
- ST
Smach Thomas J
$76K
bought
- ST
Smach Thomas J
$438K
bought
How top traders are positioned
No tracked top-trader positions in CROX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 5.3% above what analysts expected.
Last report
Jul 30, 2026
Period ending
Jun 30, 2026
Earnings per share
$4.32 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $4.55 / $4.32Alpha Vantage | +5.32% beat | Unavailable | Unavailable |
| Mar 31, 2026 | Apr 30, 2026 | $2.99 / $2.79Alpha Vantage | +7.17% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 12, 2026 | $2.29 / $1.91Alpha Vantage | +19.90% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 30, 2025 | $2.92 / $2.36Alpha Vantage | +23.73% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $4.23 / $4.01Alpha Vantage | +5.49% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $3.00 / $2.49Alpha Vantage | +20.48% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 13, 2025 | $2.52 / $2.26Alpha Vantage | +11.50% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 29, 2024 | $3.60 / $3.11Alpha Vantage | +15.76% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 29, 2026, in 23 days
Estimates as of Oct 4, 2026
EPS expected
$3.25 to $3.37
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $996.3M | $957.6M | $921.5M | $1.18B |
| Cost of what it sold | $413.3M | $434.0M | $398.5M | $478.8M |
| Gross profit | $583.0M | $523.7M | $522.9M | $700.7M |
| What it spent | ||||
| Sales and admin | $375.3M | $343.4M | $322.1M | $415.0M |
| Other operating costs | — | $33.8M | — | — |
| Total operating expenses | $375.3M | $377.3M | $322.1M | $415.0M |
| What was left | ||||
| Operating profit | $207.7M | $146.4M | $200.8M | $285.7M |
| Interest on debt | $21.7M | $21.3M | $20.5M | $60.8M |
| Profit before tax | $189.4M | $127.2M | $178.8M | $263.9M |
| Tax | $43.6M | $22.1M | $41.3M | $59.0M |
| Net profit | $145.8M | $105.2M | $137.6M | $204.9M |
| EBITDA | $231.5M | $169.4M | $219.5M | $267.0M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Crocs Inc (CROX) Shares Fall 4.3% -- What GF Score of 85 Tells I
Leans bullishOct 1Crocs (NASDAQ:CROX) Stock Crosses Above 200 Day Moving Average - Should You Sell?
Leans bullishOct 1Crocs, Inc. (CROX) Stock Price, News, Quote & History
Leans bullishSep 30Why Crocs Wants Its Old Clogs Back
Leans bullishSep 30Return on assets % of Crocs, Inc. – HAN:C7N
NeutralSep 30Pochita Is Being Turned Into a Croc — 4 Chainsaw Man Clog Designs Coming to Foot Locker This Fall
NeutralSep 30EBITDA margin % of Crocs, Inc. – HAN:C7N
NeutralSep 29(CROX) Movement Within Algorithmic Entry Frameworks
NeutralSep 29
Macro
11 macro signals shaping CROX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results